Form 4: Natera Co-Founder Jonathan Sheena Sells Shares Under 10b5-1 Trading Plan

Jonathan Sheena, co-founder of Natera, Inc., sold a portion of their common stock holdings on May 10, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 10, 2024, Jonathan Sheena, a co-founder of Natera, Inc., executed multiple sales of Natera's common stock.
• The sales were conducted under a Rule 10b5-1 trading plan adopted on December 12, 2023.
• A total of 349 shares were sold at a weighted average price of $103.0571, with individual prices ranging from $102.87 to $103.57.
• An additional 990 shares were sold at a weighted average price of $104.6049, with individual prices ranging from $103.99 to $104.95.
• Further sales included 660 shares at a weighted average price of $105.5091 (ranging from $105.00 to $105.86) and 611 shares at a weighted average price of $106.3163 (ranging from $106.16 to $106.98).
• Finally, 90 shares were sold at $107.48 per share.
• Following these transactions, Sheena directly owns 319,061 shares of Natera common stock.
• Sheena also indirectly owns 69,082 shares through the Caraluna 1 Trust and another 69,082 shares through the Caraluna 2 Trust, both held for the benefit of their minor children, with Sheena disclaiming beneficial ownership.
• Sheena is a director and co-founder of Natera.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan. There's no indication of positive or negative implications for the company's performance.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under a 10b5-1 plan are generally viewed as less informative.

Comparison to Industry Standards

• Comparing insider trading activity to companies like Exact Sciences (EXAS) or Guardant Health (GH) can provide context.
• However, each company's insider activity is unique and depends on individual circumstances and pre-arranged trading plans.
• It's important to consider the size of the transactions relative to the insider's total holdings and the overall trading volume of the stock.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market.
• However, given the pre-planned nature of the sales and the relatively small volume compared to the overall market capitalization of Natera, the impact is likely to be minimal.

Key Dates